Appl Clin Inform 2014; 05(03): 603-611
DOI: 10.4338/ACI-2014-04-RA-0030
Research Article
Schattauer GmbH

Estimation of severe drug-drug interaction warnings by medical specialist groups for Austrian nationwide eMedication

C. Rinner
1  Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna
,
S. K. Sauter
1  Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna
,
L. M. Neuhofer
1  Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna
,
D. Edlinger
1  Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna
,
W. Grossmann
2  Research Group Scientific Computing, University of Vienna
,
M. Wolzt
3  Department of Clinical Pharmacology, Medical University of Vienna
,
G. Endel
4  Main Association of Austrian Social Security Organizations, Vienna, Austria
,
W. Gall
1  Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna
› Author Affiliations
Further Information

Publication History

received: 14 April 2014

accepted: 21 May 2014

Publication Date:
19 December 2017 (online)

Summary

Objective: The objective of this study is to estimate the amount of severe drug-drug interaction warnings per medical specialist group triggered by prescribed drugs of a patient before and after the introduction of a nationwide eMedication system in Austria planned for 2015.

Methods: The estimations of interaction warnings are based on patients’ prescriptions of a single health care professional per patient, as well as all patients’ prescriptions from all visited health care professionals. We used a research database of the Main Association of Austrian Social Security Organizations that contains health claims data of the years 2006 and 2007.

Results: The study cohort consists of about 1 million patients, with 26.4 million prescribed drugs from about 3,400 different health care professionals. The estimation of interaction warnings show a heterogeneous pattern of severe drug-drug-interaction warnings across medical specialist groups.

Conclusion: During an eMedication implementation it must be taken into consideration that different medical specialist groups require customized support.

Citation: Rinner C, Sauter SK, Neuhofer LM, Edlinger D, Grossmann W, Wolzt M, Endel G, Gall W. Estimation of severe drug-drug interaction warnings by medical specialist groups for Austrian nationwide eMedication. Appl Clin Inf 2014; 5: 603–611

http://dx.doi.org/10.4338/ACI-04-RA-0030